Selection of Tobacco Harm Reduction Stakeholders' Views
Harm reduction approaches have produced diverse opinions from numerous stakeholders. We encourage anyone interested in learning more about Tobacco Harm Reduction (THR) to read more and consider the broadest range of available viewpoints.
- The World Health Organization (WHO) takes the view that: "ENDS [(electronic nicotine delivery systems)] contain varying amounts of nicotine and harmful emissions. E-cigarette emissions typically contain nicotine and other toxic substances that are harmful to both users and non-users who are exposed to the aerosols second-hand. Some products claiming to be nicotine-free (ENNDS) [(electronic non-nicotine delivery systems)] have been found to contain nicotine. Nicotine exposure in pregnant women can adversely affect the development of the fetus. Further, the consumption of nicotine in children and adolescents has negative impacts on brain development, leading to long-term consequences for brain development and potentially leading to learning and anxiety disorders."[1]
- In the U.S. the Food and Drug Administration (FDA) has acknowledged a risk continuum of tobacco and nicotine products and has regulatory pathway to introduce new products and to market products as reduced risk.[2]
- In the UK, Public Health England^ and the Government have adopted harm reduction as a key pillar of tobacco control.[3]
